Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.7 CAD | 0.00% |
|
-1.10% | +145.45% |
Jun. 26 | ROTH MKM Initiates Coverage on Cardiol Therapeutics With Buy Rating, $10 Price Target | MT |
Jun. 13 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+145.45% | 135M | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- CRDL Stock
- News Cardiol Therapeutics Inc.
- Cardiol Therapeutics : Upgraded to Outperform at Raymond James as First Patient Enrolled in Clinical Trial